Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Empagliflozin”

425 trials

Showing 20 of 425 results

Post-approval studies (Phase 4)Looking for participantsNCT06021145
What this trial is testing

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes

Who this might be right for
Type 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre 46
Testing effectiveness (Phase 2)Study completedNCT05081219
What this trial is testing

SNIFF - Combo INI+EMPA Trial

Who this might be right for
Mild Cognitive ImpairmentCognitive ImpairmentAlzheimer Disease
Wake Forest University Health Sciences 47
Testing effectiveness (Phase 2)Study completedNCT07169981
What this trial is testing

Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF

Who this might be right for
Diabete MellitusHeart FailureRemodeling, Left Ventricle
Ain Shams University 200
Post-approval studies (Phase 4)Study completedNCT03193684
What this trial is testing

Empagliflozin and Hepatic Glucose Metabolism

Who this might be right for
Hepatic Glucose Metabolism
The University of Texas Health Science Center at San Antonio 72
Post-approval studies (Phase 4)Ended earlyNCT03642184
What this trial is testing

Efficacy and Safety of Empagliflozin in NODAT

Who this might be right for
New Onset Diabetes After TransplantKidney Transplant; Complications
RenJi Hospital 6
Post-approval studies (Phase 4)Study completedNCT04910178
What this trial is testing

Follow-up of NAFLD Patients With MRI-PDFF

Who this might be right for
Diabetes Type 2NAFLD
Asmaa Abdelfattah Elsayed 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175051
What this trial is testing

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Who this might be right for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Albuminuria
University of Illinois at Chicago 20
Not applicableLooking for participantsNCT07023172
What this trial is testing

Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets

Who this might be right for
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06683053
What this trial is testing

Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department

Who this might be right for
Congestive Heart Failure (CHF)
Conrado Roberto Hoffmann Filho 90
Testing effectiveness (Phase 2)Study completedNCT00885118
What this trial is testing

4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 100
Large-scale testing (Phase 3)Study completedNCT02863328
What this trial is testing

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 822
Post-approval studies (Phase 4)Study completedNCT04117763
What this trial is testing

Effect of Empagliflozin on Ventricular Repolarization.

Who this might be right for
Diabetes Mellitus, Type 2Coronary Heart DiseaseArrythmia, Cardiac
University of Sao Paulo 90
Large-scale testing (Phase 3)Ended earlyNCT03060980
What this trial is testing

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Intarcia Therapeutics 245
Large-scale testing (Phase 3)WithdrawnNCT01984606
What this trial is testing

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim
Post-approval studies (Phase 4)Study completedNCT02932436
What this trial is testing

Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2Diastolic Dysfunction
Johannes Gutenberg University Mainz 144
Large-scale testing (Phase 3)Study completedNCT02874807
What this trial is testing

Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study

Who this might be right for
SIADH
University Hospital, Basel, Switzerland 88
Post-approval studies (Phase 4)Looking for participantsNCT06013865
What this trial is testing

Empagliflozin Treatment in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantChronic Kidney Disease
VA Office of Research and Development 264
Not applicableStudy completedNCT03817463
What this trial is testing

Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 327,624
Early research (Phase 1)Study completedNCT02821910
What this trial is testing

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT01211197
What this trial is testing

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 16
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation